Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tegaserod Extension for Opioid-Induced Constipation
NCT00399659Phase 3Terminated
- Sponsor
- Novartis
- Start
- Nov 2006
- Primary completion
- Apr 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tegaserod in opioid-induced constipation (OIC), sponsored by Novartis. Started Nov 2006; status: terminated.
02
Drugs
tegaserod
03
Conditions
opioid-induced constipation (OIC)
Beyond the preview
Go deeper on NCT00399659.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00399659.